Results 31 to 40 of about 562 (139)

Clinical Characteristics and Treatment Outcomes of Scleromyxedema: A 10-Year Retrospective Survey

Case Reports in Dermatology, 2022
Scleromyxedema is a rare but important mucinosis disorder of the skin that is presented with dermatological manifestations such as waxy papules, diffuse induration, and nondermatologic involvements like neurological and renal disorders.
Abtin Ansari, Zohre Erfani, Maryam Daneshpazhooh, Leila Mahmoudi, Zahra Saffarian, Kambiz Kamyab, Hamidreza Mahmoudi   +6 more
doaj   +1 more source

Localized eruption of glabella and eyebrows [PDF]

JAAD Case Reports
Celestina Okoye, MD, Kai Brady, BS, Jennifer Shastry, MD   +2 more
doaj   +2 more sources

Coexistence of scleromyxedema and Sneddon syndrome

JAAD Case Reports, 2021
Giampiero Girolomoni, Francesco Bellinato, Chiara Colato   +2 more
exaly   +3 more sources

Lichen myxedematosus: a rare group of cutaneous mucinosis [PDF]

Anais Brasileiros de Dermatologia
: Cutaneous mucinoses are a heterogeneous group of dermatoses in which excess deposition of mucin in the dermis gives the skin a waxy appearance, with papules and plaques that can vary from self-healing mucinosis to even disrupting the normal shape of a ...
Ramiro Eugenio Cárdenas-Gonzalez, Maira Elizabeth Herz Ruelas, Jorge Ocampo Candiani   +2 more
doaj   +2 more sources

Severe cutaneous scleromyxedema treated by lenalidomide

JEADV Clinical Practice, 2023
Scleromyxedema is a rare clinical variant of primary cutaneous mucinosis. It is defined by a generalized papular and sclerodermoid eruption associated with monoclonal gammopathy. No specific definitive treatment is known and those tried have inconsistent
Théo Brochet, Ali Dadban, Quentin Beauvillain, Clemence Boucher, Fanny Dessirier, Christophe Attencourt, Catherine Lok, Pierre Morel, Aurélie Halle, Guillaume Chaby   +9 more
doaj   +1 more source

Early onset of scleromyxedema Arndt‐Gottron associated with a monoclonal gammapathy: Successful treatment with intravenous immunoglobulins

Clinical Case Reports, 2022
Arndt‐Gottron (S‐AG) syndrome or scleromyxedema is a scarce disease characterized by a generalized papular and sclerodermoid eruption and systemic manifestations that can lead to significant morbid‐mortality.
Asma Kefi, Fatima Jaziri, Khaoula Ben Abdelghani, Sami Turki   +3 more
doaj   +1 more source

Scleromyxedema concurrent with dermatomyositis and paraproteinemia: A case report

Современная ревматология, 2015
The paper describes the case of a female patient who had at least three diseases: scleromyxedema, dermatomyositis/polymyositis (DM/PM), and paraproteinemia (monoclonal gammopathy).
M. N. Starovoitova, O. V. Desinova, N. G. Guseva   +2 more
doaj   +1 more source

Severe but reversible pulmonary hypertension in scleromyxedema and multiple myeloma: a case report

BMC Pulmonary Medicine, 2020
Background Scleromyxedema is a progressive, systemic connective tissue disorder characterized by fibro-mucous skin lesions and increased serum monoclonal immunoglobulin levels.
Mazen Kreidy, Ali Al-Hilli, Ralph Yachoui, Jeffrey Resnick   +3 more
doaj   +1 more source

Discrete Papular Lichen Myxedematosus and Scleromyxedema with Hypothyroidism: A Report of Two Cases

Case Reports in Dermatology, 2019
Scleromyxedema and lichen myxedematosus (LM) are rare disorders that fall along the spectrum of primary cutaneous mucinoses. Scleromyxedema is a systemic form that classically presents with generalized waxy papules, sclerodermoid eruption, and monoclonal
Adele Shenoy, Jacklyn Steixner, Vincent Beltrani, Alice Gottlieb   +3 more
doaj   +1 more source

Plasma cell myeloma masquerading as scleromyxedema

Indian Dermatology Online Journal, 2019
Scleromyxedema is a rare progressive cutaneous mucinosis of unknown etiology with equal prevalence in both men and women. It is usually associated with monoclonal gammopathy in most of the cases.
Varun Victor, Rashmi Maria Margareat
doaj   +1 more source